Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido A Davidzon

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in ManagementHong Song, Caitlyn Harrison, Heying Duan, et al.
NPJ Digital Medicine|August 24, 2021
Low-count whole-body PET with deep learning in a multicenter and externally validated studyAkshay S Chaudhari, Erik Mittra, Guido A Davidzon, et al.
Radiology|September 19, 2019
Bone Marrow and Tumor Radiomics at <sup>18</sup>F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung CancerSarah A Mattonen, Guido A Davidzon, Jalen Benson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate CancerHeying Duan, Pejman Ghanouni, Bruce Daniel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2022
<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive TreatmentFarshad Moradi, Heying Duan, Hong Song, et al.
The Lancet. Oncology|February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trialHeying Duan, Farshad Moradi, Guido A Davidzon, et al.
Frontiers in Neuroscience|July 1, 2026
Brain protein burden is related to intravoxel incoherent motion: PET-MR imaging studyDimuthu Hemachandra, Kevin Zheng, Sara A Lorkiewicz, et al.
Biomedicines|January 21, 2022
Phenotypic Heterogeneity among <i>GBA</i> p.R202X Carriers in Lewy Body Spectrum DisordersValerio Napolioni, Carolyn A Fredericks, Yongha Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 2022
Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate CancerHeying Duan, Lucia Baratto, Richard E Fan, et al.
Brain Communications|January 1, 2025
<sup>18</sup>F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body diseaseJoseph R Winer, Hillary Vossler, Christina B Young, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in ManagementHong Song, Caitlyn Harrison, Heying Duan, et al.
NPJ Digital Medicine|August 24, 2021
Low-count whole-body PET with deep learning in a multicenter and externally validated studyAkshay S Chaudhari, Erik Mittra, Guido A Davidzon, et al.
Radiology|September 19, 2019
Bone Marrow and Tumor Radiomics at <sup>18</sup>F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung CancerSarah A Mattonen, Guido A Davidzon, Jalen Benson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate CancerHeying Duan, Pejman Ghanouni, Bruce Daniel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2022
<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive TreatmentFarshad Moradi, Heying Duan, Hong Song, et al.
The Lancet. Oncology|February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trialHeying Duan, Farshad Moradi, Guido A Davidzon, et al.
Frontiers in Neuroscience|July 1, 2026
Brain protein burden is related to intravoxel incoherent motion: PET-MR imaging studyDimuthu Hemachandra, Kevin Zheng, Sara A Lorkiewicz, et al.
Biomedicines|January 21, 2022
Phenotypic Heterogeneity among <i>GBA</i> p.R202X Carriers in Lewy Body Spectrum DisordersValerio Napolioni, Carolyn A Fredericks, Yongha Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 2022
Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate CancerHeying Duan, Lucia Baratto, Richard E Fan, et al.
Brain Communications|January 1, 2025
<sup>18</sup>F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body diseaseJoseph R Winer, Hillary Vossler, Christina B Young, et al.
Pageof 3